THU-240 30% of inactive HBsAg carriers achieved clinical cure at 48 weeks with Pegylated Interferon alpha-2b therapy: a multicenter real- world study (STARHB Project in China)- 2.5 years data update
Shan Ren(Xi'an Jiaotong University), Xinyue Chen(Sichuan University), Tianyuan Shi, Shuangsuo Dang, Ying Guo(Lingnan University), Zhiliang Gao(Sun Yat-sen University), Qing Mao, Jiawei Geng, Yilan Zeng(Public Health Clinical Center of Chengdu), Sujun Zheng(Beijing Tian Tan Hospital), Haibing Gao(Fujian Medical University), Jing Zhao(Beijing Tongren Hospital), Haidong Zhao, Yingli He(Emory University), Rongshan Fan, Wenhua Zhang(University of Science and Technology of China), Zu‐Jiang Yu, Haifang Cao, Xiaoping Wu(Nanchang University), Yan Huang(Central South University), Xiaorong Mao(First Hospital of Lanzhou University), Yongfang Jiang(Central South University), Bingliang Lin(Sun Yat-sen University), Xiulan Xue, Jia Shang(European Foundation for the Study of Chronic Liver Failure)
Cited by 0
Related Papers
Psychological impacts and coping strategies of front-line medical staff during COVID-19 outbreak in Hunan, China
|Medical Science Monitor|2020|784
CO2 mineral carbonation using industrial solid wastes: A review of recent developments
|Chemical Engineering Journal|2021|480
V2O5-modified Mn-Ce/AC catalyst with high SO2 tolerance for low-temperature NH3-SCR of NO
|Chemical Engineering Journal|2019|300
p38 MAPK inhibits autophagy and promotes microglial inflammatory responses by phosphorylating ULK1
|The Journal of Cell Biology|2017|281
In situ IR comparative study on N2O formation pathways over different valence states manganese oxides catalysts during NH3–SCR of NO
|Chemical Engineering Journal|2020|233